Skip to main content
. 2022 Dec 16;101(50):e32246. doi: 10.1097/MD.0000000000032246

Table 7.

Systolic blood pressure and its subgroup outcomes.

Outcomes Risk of bias Inconsistency Indirectness Imprecision Other considerations Quality of evidence
SBP Serious* No serious No serious No serious None ⊕⊕⊕◯
MODERATE
Subgroup of SBP
Dynamic monitoring time
 Daytime Serious* No serious No serious Serious None ⊕⊕◯◯
LOW
 Evening Serious* Serious No serious Serious None ⊕◯◯◯
VERY LOW
Blood pressure range
 Hypertension Serious* No serious No serious Serious None ⊕⊕◯◯
LOW
 Pre-hypertension Serious* No serious No serious No serious None ⊕⊕⊕◯
MODERATE
Exercise frequency
 <3 times No serious No serious No serious Serious None ⊕⊕⊕◯
MODERATE
 ≥3 times Serious* No serious No serious No serious None ⊕⊕⊕◯
MODERATE
 ≥5 times Serious* No serious No serious Serious None ⊕⊕◯◯
LOW
Training cycle
 <8 wk No serious No serious No serious Serious None ⊕⊕⊕◯
MODERATE
 ≥8 wk Serious* No serious No serious No serious None ⊕⊕⊕◯
MODERATE
 ≥12 wk Serious* No serious No serious Serious None ⊕⊕◯◯
LOW
 ≥16 wk Serious* No serious No serious Serious None ⊕⊕◯◯
LOW

GRADE Working Group grades of evidence.

High certainty: We are very confident that the true effect lies close to that of the estimate of the effect.

Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.

Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.

Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.

*

Incomplete outcome data.

The sample size is small.

Results were highly heterogeneous across included studies.